BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 15984999)

  • 1. Interstitial pneumonia recurrence during chronic hepatitis C treatment.
    Renou C; Germain S; Harafa A; Martin S; Larroque O; Muller P; Bertrand JJ; Halfon P
    Am J Gastroenterol; 2005 Jul; 100(7):1625-6. PubMed ID: 15984999
    [No Abstract]   [Full Text] [Related]  

  • 2. A change of peginterferon may permit continuation of antiviral therapy in hepatitis C virus-infected patients with interstitial pneumonitis.
    Shimada M; Yoshida S; Kornek M; Kim SJ; Schuppan D
    Liver Int; 2010 Nov; 30(10):1552-4. PubMed ID: 20557455
    [No Abstract]   [Full Text] [Related]  

  • 3. Interstitial pneumonitis during combination therapy with interferon-alpha and ribavirin in a patient with chronic Hepatitis C.
    Rothfuss KS; Bode JC
    Z Gastroenterol; 2002 Sep; 40(9):807-10. PubMed ID: 12215950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutaneous sarcoidosis associated with pegylated interferon alfa and ribavirin therapy in a patient with chronic hepatitis C.
    Rogers CJ; Romagosa R; Vincek V
    J Am Acad Dermatol; 2004 Apr; 50(4):649-50. PubMed ID: 15034524
    [No Abstract]   [Full Text] [Related]  

  • 5. Alopecia universalis: a rare side effect seen on chronic hepatitis C treatment with peg-IFN and ribavirin.
    Demirturk N; Aykin N; Demirdal T; Cevik F
    Eur J Dermatol; 2006; 16(5):579-80. PubMed ID: 17101483
    [No Abstract]   [Full Text] [Related]  

  • 6. Pulmonary complications associated with pegylated interferon and ribavirin in HIV/hepatitis C virus coinfected patients.
    Vasilij Benatti S; Giampaolo Q; Sara B; Marco R; Diego R
    AIDS; 2014 Nov; 28(17):2633-5. PubMed ID: 25574965
    [No Abstract]   [Full Text] [Related]  

  • 7. Peginterferon and ribavirin for chronic hepatitis C.
    Hoofnagle JH; Seeff LB
    N Engl J Med; 2006 Dec; 355(23):2444-51. PubMed ID: 17151366
    [No Abstract]   [Full Text] [Related]  

  • 8. Severe interstitial pneumonitis secondary to pegylated interferon alpha-2b and ribavirin treatment of hepatitis C infection.
    Fuhrmann V; Kramer L; Bauer E; Laferl H; Tucek G; Dekan G; Schenk P
    Dig Dis Sci; 2004; 49(11-12):1966-70. PubMed ID: 15628735
    [No Abstract]   [Full Text] [Related]  

  • 9. Combination pegylated interferon and ribavirin therapy precipitating acute renal failure and exacerbating IgA nephropathy.
    Gordon A; Menahem S; Mitchell J; Jenkins P; Dowling J; Roberts SK
    Nephrol Dial Transplant; 2004 Aug; 19(8):2155. PubMed ID: 15252182
    [No Abstract]   [Full Text] [Related]  

  • 10. [Combination therapy for chronic viral hepatitis C].
    Zeuzem S
    Dtsch Med Wochenschr; 2003 Feb; 128(8):370-4. PubMed ID: 12594622
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cutaneous reactions induced by pegylated-interferon plus ribavirin combination therapy in a patient with chronic hepatitis C].
    Enjoji M; Dainichi T; Gondo H; Urabe K
    Fukuoka Igaku Zasshi; 2007 Sep; 98(9):353-6. PubMed ID: 17974079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generalized nummular eczema secondary to peginterferon Alfa-2b and ribavirin combination therapy for hepatitis C infection.
    Shen Y; Pielop J; Hsu S
    Arch Dermatol; 2005 Jan; 141(1):102-3. PubMed ID: 15655158
    [No Abstract]   [Full Text] [Related]  

  • 13. Simeprevir with peginterferon and ribavirin induced interstitial pneumonitis: first case report.
    Tamaki K; Okubo A
    World J Gastroenterol; 2015 Jan; 21(3):1009-13. PubMed ID: 25624738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antiviral therapy of patients with chronic hepatitis C with normal level of aminotransferases].
    Lopukhova NL
    Eksp Klin Gastroenterol; 2007; (4):146-52. PubMed ID: 18409502
    [No Abstract]   [Full Text] [Related]  

  • 15. Thyrotoxic periodic paralysis induced by pegylated interferon alpha plus ribavirin for chronic hepatitis C.
    Yang WS; Chu PL; Liu CH; Chung GB; Wu KD
    J Clin Gastroenterol; 2008 Jan; 42(1):112-3. PubMed ID: 18097301
    [No Abstract]   [Full Text] [Related]  

  • 16. Pegylated interferon and ribavirin-induced interstitial pneumonitis with ARDS.
    Abi-Nassif S; Mark EJ; Fogel RB; Hallisey RK
    Chest; 2003 Jul; 124(1):406-10. PubMed ID: 12853555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetic ketoacidosis induced by alpha interferon and ribavirin treatment in a patient with hepatitis C.
    Bhatti A; McGarrity TJ; Gabbay R
    Am J Gastroenterol; 2001 Feb; 96(2):604-5. PubMed ID: 11232722
    [No Abstract]   [Full Text] [Related]  

  • 18. [Interferon-alpha and ribavirin: advances in the therapy of chronic hepatitis C].
    Zeuzem S
    Dtsch Med Wochenschr; 1999 May; 124(20):636-42. PubMed ID: 10370387
    [No Abstract]   [Full Text] [Related]  

  • 19. [Respiratory function impairment during treatment of chronic hepatitis C with peginterferon alfa2 and ribavirin. Two cases presentation].
    Biedroń-Machura M; Musialik J; Sozańska E; Zbroszczyk M; Baron J; Błońska-Fajfrowska B; Pierzchała W
    Wiad Lek; 2012; 65(4):232-8. PubMed ID: 23654144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon and ribavirin treatment for chronic hepatitis C may activate celiac disease.
    Adinolfi LE; Durante Mangoni E; Andreana A
    Am J Gastroenterol; 2001 Feb; 96(2):607-8. PubMed ID: 11232725
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.